About

Cancer Research

The behavior of a tumor and its response to specific cancer therapies are difficult to predict. They largely depend on its cellular morphology, tumor metabolism and the genetic and epigenetic changes accumulating in the tumor cells. But they are also influenced by the tumor micro-environment, which consists of, among others, the tumor vasculature and infiltrating immune cells. To advance the understanding of cancer biology and treatment, a multidisciplinary approach is needed. Within VIB, scientists conduct both strategic basic and translational research into cancer.

News

Impact on society

Toward new cancer medicines

Toward new cancer medicines

Medulloblastoma is a rare, life-threatening brain tumor that mainly affects children. Research carried out by Peter Carmeliet (VIB-KU Leuven) and colleagues provided the basis for a new potential drug: TB-403.
Read more
Contagious

Contagious

An in-dept characterization of the dynamic immune response to coronavirus SARS-CoV-2 in the Contagious project.
Read more

Center for Cancer Biology

The ambition of the Center for Cancer Biology (CCB) is to contribute to a better understanding of the biology underlying cancer initiation, progression and metastatic dissemination. We aim to identify novel biomarkers for the early detection, monitoring of cancer progression and therapy response and, ultimately, develop more effective anticancer therapies.

Start ups